Andover, MA, United States of America

Zachary Kops

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Deka Limited Partnership. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Zachary Kops in Bioreactor Systems

Introduction

Zachary Kops is an innovative inventor based in Andover, MA (US). He has made significant contributions to the field of bioreactor systems, particularly in the area of tissue growth processes. His work focuses on creating systems that enhance the efficiency and effectiveness of manufacturing lines in biotechnological applications.

Latest Patents

Zachary Kops holds 1 patent for a "Modular, configurable bioreactor system for a manufacturing line." This patent describes a configurable system designed for repeatably performing processes related to tissue growth in a controlled environment. The system is capable of accommodating various sizes and shapes of culture vessels while maintaining the cells at a desired temperature. This plug-and-play system ensures consistent and repeatable results, which is crucial for industrial production lines.

Career Highlights

Kops is associated with Deka Limited Partnership, where he applies his expertise in developing advanced bioreactor technologies. His innovative approach has positioned him as a key player in the field, contributing to the advancement of automated process control and centralized data management in tissue-related manufacturing.

Collaborations

Zachary collaborates with notable colleagues, including Richard E. Andrews and Justin M. Ferrentino. Their combined efforts enhance the development of cutting-edge technologies in the bioreactor domain.

Conclusion

Zachary Kops is a prominent inventor whose work in modular bioreactor systems is paving the way for advancements in tissue growth manufacturing. His contributions are vital for the future of biotechnological processes, ensuring efficiency and reliability in production lines.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…